Mono Pharmacare Limited (NSE:MONOPHARMA)
India flag India · Delayed Price · Currency is INR
24.30
-1.25 (-4.89%)
At close: Jul 14, 2025

Mono Pharmacare Ratios and Metrics

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 20212020
Period Ending
Jul '25 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21 2020
429408779---
Upgrade
Market Cap Growth
-47.62%-47.62%----
Upgrade
Enterprise Value
9588941,134---
Upgrade
Last Close Price
24.3023.1044.10---
Upgrade
PE Ratio
13.8913.2131.90---
Upgrade
PS Ratio
0.250.240.64---
Upgrade
PB Ratio
1.371.312.77---
Upgrade
P/TBV Ratio
1.381.312.77---
Upgrade
EV/Sales Ratio
0.570.530.93---
Upgrade
EV/EBITDA Ratio
11.1210.3817.83---
Upgrade
EV/EBIT Ratio
11.2910.5417.98---
Upgrade
Debt / Equity Ratio
1.721.721.472.921.511.65
Upgrade
Debt / EBITDA Ratio
6.226.226.5217.374.636.34
Upgrade
Debt / FCF Ratio
----28.52-
Upgrade
Asset Turnover
1.771.771.700.862.902.85
Upgrade
Inventory Turnover
3.123.122.951.567.857.50
Upgrade
Quick Ratio
0.810.810.890.660.670.84
Upgrade
Current Ratio
2.072.072.241.821.641.66
Upgrade
Return on Equity (ROE)
10.46%10.46%11.76%10.52%8.80%3.33%
Upgrade
Return on Assets (ROA)
5.55%5.55%5.49%3.65%6.27%5.21%
Upgrade
Return on Capital (ROIC)
6.87%6.87%6.40%4.37%7.83%5.73%
Upgrade
Return on Capital Employed (ROCE)
14.80%14.80%13.90%7.70%22.20%17.70%
Upgrade
Earnings Yield
7.20%7.57%3.14%---
Upgrade
FCF Yield
-10.55%-11.10%----
Upgrade
Buyback Yield / Dilution
-14.23%-14.23%-172.89%-15.18%--
Upgrade
Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.